Hongqi Pharmaceutical
HONGQI PHARMACEUTICAL
Cherish life, pay attention to health.
CHERISH LIFE CARE ABOUT HEALTH
Hongqi Pharmaceutical was invited to participate in the research symposium of the State Food and Drug Administration on the consistency evaluation of generic drugs
Category:
Company News
Author:
Source:
Add time:2016-09-06 14:49
Summary:On August 24th, Sun Xianze, Deputy Director of the State Food and Drug Administration and Director of Drug Safety, attended the National Food and Drug Safety Emergency Management Work Conference in Shenyang and gave a speech, and then investigated some drug manufacturers in Liaoning to evaluate the quality and efficacy of generic drugs.
On August 24th, Sun Xianze, Deputy Director of the State Food and Drug Administration and Director of Drug Safety, attended the National Food and Drug Safety Emergency Management Work Conference in Shenyang and gave a speech, and then investigated some drug manufacturers in Liaoning to evaluate the quality and efficacy of generic drugs. Four companies including Shenyang Hongqi Pharmaceutical Co., Ltd. and Dongyao Group were invited to participate in a discussion with business representatives.
Deputy Director Sun Xianze pointed out that the consistency evaluation work is both a challenge and an opportunity. Enterprises should give full play to the main role and carry out the consistency evaluation work as early as possible in a selective manner. It is necessary to make good use of various policies, and strive to obtain the first opportunity in the competition for the varieties that are evaluated for consistency. The food and drug regulatory authorities will continue to improve the working mechanism to provide services and technical guidance for enterprises.
Liu Xuejun, vice president of the Research Institute of Shanghai Fosun Pharmaceutical Industry Development Co., Ltd., Yang Bo, general manager of Shenyang Hongqi Pharmaceutical Co., Ltd., and Sun Jukui, deputy director of R&D, attended the meeting. During the meeting, company leaders communicated effectively with leaders at all levels of the country, provinces and cities. General Manager Yang Bo expressed his views on the problems encountered by Shenyang Hongqi Pharmaceutical Co., Ltd. in the consistency evaluation of anti-tuberculosis drugs. Leaders at all levels and peers frequently Nodded in agreement; President Liu Xuejun introduced Fosun Pharma’s overall work on consistency evaluation, which was also approved by Deputy Director Sun Xianze.
Through this symposium, the work of Fosun Pharma and Shenyang Hongqi was recognized by leaders at all levels of the drug regulatory system, and demonstrated our company's good work style and corporate style. This exchange not only allowed the company to obtain more information and work ideas, but also played a positive role in promoting the company.
